The nuclear hormone receptor PPAR gamma promotes adipogenesis and macrophag
e differentiation and is a primary pharmacological target in the treatment
of type II diabetes. Here, we show that PPAR gamma gene knockout results in
two independent lethal phases. Initially, PPAR gamma deficiency interferes
with terminal differentiation of the trophoblast and placental vasculariza
tion, leading to severe myocardial thinning and death by E10.0. Supplementi
ng PPAR gamma null embryos with wild-type placentas via aggregation with te
traploid embryos corrects the cardiac defect, implicating a previously unre
cognized dependence of the developing heart on a functional placenta. A tet
raploid-rescued mutant surviving to term exhibited another lethal combinati
on of pathologies, including lipodystrophy and multiple hemorrhages. These
findings both confirm and expand the current known spectrum of physiologica
l functions regulated by PPAR gamma.